Evolving Antibiotics against Resistance: a Potential Platform for Natural Product Development?

Area of Science:

• Microbiology
• Evolutionary Biology
• Drug Discovery

Background:

• Antibiotic resistance is a growing global health crisis, necessitating novel drug development strategies.
• Current antibiotic discovery methods, such as target-based screening and rational design, struggle to address the complexity of antibiotic functions and resistance mechanisms.
• The pace of antibiotic development has not kept up with the rapid evolution of microbial resistance.

Purpose of the Study:

• To propose a novel methodology for evolving antibiotics capable of circumventing existing resistance mechanisms.
• To highlight the potential of laboratory-based evolution to address the challenges in developing new antibiotics.
• To review the theoretical underpinnings of evolutionary approaches for antibiotic discovery.

Main Methods:

• Experimental evolution studies of microbes, with a specific focus on antibiotic production in Actinobacteria.
• Application of evolutionary theory to guide the development of antibiotic evolution strategies.
• Comparative analysis of evolutionary approaches against traditional drug discovery methods.

Main Results:

• Demonstrated feasibility of evolving antibiotics to overcome complex resistance mechanisms.
• Identified advantages of evolutionary approaches over current drug discovery paradigms.
• Provided a framework for utilizing laboratory evolution to accelerate antibiotic development.

Conclusions:

• Laboratory evolution offers a powerful and feasible strategy to develop new antibiotics that can outpace microbial resistance.
• This approach exploits evolution's inherent ability to solve complex biological problems without explicit design.
• Evolving antibiotics presents significant advantages for combating the antibiotic resistance crisis.